Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Combined Use of wIRA and Microwave or Radiofrequency Hyperthermia

J. Crezee  1 , A. Bakker  1 , R. Zweije  1 , M. W. Kolff  1 , H. J. G. D. van den Bongard  1 , G. van Tienhoven  1 , H. P. Kok  1
Peter Vaupel  1
, editors.
In: Water-filtered Infrared A (wIRA) Irradiation: From Research to Clinical Settings [Internet]. Cham (CH): Springer; 2022. Chapter 7.
.
Affiliations
Free Books & Documents
Review

Combined Use of wIRA and Microwave or Radiofrequency Hyperthermia

J. Crezee et al.
Free Books & Documents

Excerpt

Clinical hyperthermia (i.e., heating of tumor tissue to 40–43 °C) is used in clinical oncology to enhance the therapeutic effect of chemotherapy and radiotherapy. Most recurrent breast cancer and melanoma lesions reach up to a few cm deep and can be effectively treated with currently available superficial hyperthermia devices using infrared or microwave radiation. Effective heating of more challenging and complex semi-superficial or semi-deep tumor lesions, including intact breast or lesions near silicone implants, requires dedicated treatment protocols. Herein, new treatment protocols are presented, which combine simultaneous and consecutive use of different wIRA, microwave, and radiofrequency hyperthermia devices. Examples are included, showing the clinical setup, applicator choice, and invasive and noninvasive thermometry.

PubMed Disclaimer

References

    1. Cihoric N, Tsikkinis A, van Rhoon G, Crezee H, Aebersold DM, Bodis S, et al. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperthermia. 2015;31(6):609–14. - PubMed
    1. Datta NR, Gomez Ordonez S, Gaipl US, Paulides MM, Crezee H, Gellermann J, et al. Local hyperthermia combined with radiotherapy and−/ or chemotherapy: recent advances and promises for the future. Cancer Treat Rev. 2015;41(9):742–53. - PubMed
    1. Peeken JC, Vaupel P, Combs SE. Integrating hyperthermia into modern radiation oncology: what evidence is necessary? Front Oncol. 2017;7:132. - PMC - PubMed
    1. Bakker A, van der Zee J, van Tienhoven G, Kok HP, Rasch CRN, Crezee H. Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: a systematic review. Int J Hyperthermia. 2019;36(1):1024–39. - PubMed
    1. Bakker A, Kolff MW, Holman R, van Leeuwen CM, Korshuize-van Straten L, R. Oldenhof-de kroon et al., "Thermal skin damage during reirradiation and hyperthermia is time temperature dependent". Int J Radiat Oncol Biol Phys. 2017;98(2):392–9. - PubMed

LinkOut - more resources